• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Fexofenadine Hydrochloride

Fexofenadine Hydrochloride

Product ID F1895
Cas No. 153439-40-8
Purity ≥98%
Product Unit SizeCostQuantityStock
25 mg $82.70 In stock
100 mg $206.60 In stock
500 mg $299.70 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Fexofenadine is a second-generation histamine H1 receptor antagonist. Fexofenadine exhibits antihistamine activity and is clinically used to treat seasonal allergic rhinitis.

Product Info

Cas No.

153439-40-8

Purity

≥98%

Formula

C32H39NO4 • HCl

Formula Wt.

538.12

IUPAC Name

2-[4-[1-hydroxy-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-yl]butyl] phenyl]-2-methylpropanoic acid;hydrochloride

Synonym

Allegra, Telfast

Melting Point

148-150°C

Solubility

DMSO to 50 mM, water to 2 mg/mL, ethanol to 107 mg/mL, methanol

Appearance

A White Crystalline Powder

Shipping and Storage

Store Temp

4°C

Ship Temp

Ambient

Downloads

MSDS

F1895 MSDS PDF

Info Sheet

F1895 Info Sheet PDF

References

Compalati E, Baena-Cagnani R, Penagos M, et al. Systematic review on the efficacy of fexofenadine in seasonal allergic rhinitis: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials. Int Arch Allergy Immunol. 2011;156(1):1-15. PMID: 21969990.

Smith SM, Gums JG. Fexofenadine: biochemical, pharmacokinetic and pharmacodynamic properties and its unique role in allergic disorders. Expert Opin Drug Metab Toxicol. 2009 Jul;5(7):813-22. PMID: 19545214.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • C2845

    Levo-Chloramphenicol

    Protein translation inhibitor, peptidyl transferas...
    ≥98%
  • D3353

    Diminazene Aceturate

    Diamidine; ACE2 activator, DNA polymerase inhibito...
    ≥98%
  • A0832

    Ac-IEAR-pNA

    Caspase substrate.
    ≥95%
  • A6268

    Aprotinin

    Polypeptide; serine protease inhibitor.
    ≥ 5400 u/mg
  • P7608

    PTC124

    Read-through agent and nonsense mutation targeter.
    ≥98%
  • S7908

    Suc-APA-pNA

    Elastase substrate.
    ≥95%
  • B0396

    BAY80-6946

    p110α PI3K inhibitor.
    ≥98%
  • I524086

    Incensol

    Component of Frankincense resin.
    ≥98%
  • R0351

    Ramoplanin

    Peptide; peptidoglycan inhibitor.
    ≥98%
  • N5550

    Nomilin

    Triterpene found in species of Citrus; HIV-1 prote...
    ≥98%
  • C1600

    Carcinoembryonic Antigen (605-613)

    Carcinoembryonic antigen epitope.
    ≥95%
  • T3034

    Thienylethyl Isothiocyanate

    Thienylbutyl ITC analog.
    ≥98%
  • C2916

    Chenodeoxycholic Acid

    Endogenous bile acid; FXR agonist.
    ≥98%
  • A3080

    AHU-377 Tris Salt

    LBQ657 prodrug; neprilysin inhibitor.
    ≥99%
  • P3313

    Pidotimod

    Immunostimulator, adjuvant.
    ≥98%
  • A2054

    Aflatoxin M2

    Mycotoxin produced by species of Aspergillus; DNA ...
    ≥98%
  • N859614

    NVP-LDE225

    Smo inhibitor.
    ≥98%
  • A4577

    Alsterpaullone

    GSK-3 and CDK inhibitor.
    ≥98%
  • P0256

    Pantoprazole Sodium Sesquihydrate

    H+/K+ ATPase and ROCK-2 inhibitor.
    ≥98%
  • C8500

    CV-65

    1,8-Diaza-anthracene-tetrone; JNK and ERK5 inhibit...
    ≥60%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only